KEGG: ath:AT4G35130
STRING: 3702.AT4G35130.1
PCMP-H27 Antibody (Product Code: CSB-PA528652XA01DOA) is a rabbit-derived polyclonal antibody that specifically recognizes the PCMP-H27 protein (UniProt ID: O49619) from Arabidopsis thaliana (Mouse-ear cress). This antibody was developed using recombinant Arabidopsis thaliana PCMP-H27 protein as the immunogen . As a polyclonal preparation, it recognizes multiple epitopes on the target protein, making it versatile for various applications in plant molecular biology research.
The antibody is particularly valuable for researchers investigating pentatricopeptide repeat (PPR) proteins, which PCMP-H27 belongs to. These proteins are involved in RNA processing and have significant roles in organellar gene expression in plants. When designing experiments with this antibody, researchers should consider that it was developed against the specific Arabidopsis thaliana protein structure and sequence.
PCMP-H27 Antibody has been validated for the following applications:
Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative detection of the target protein in solution
Western Blotting (WB) - For identification of the target protein in complex mixtures
It's important to note that while these applications have been validated by the manufacturer, researchers should perform their own validation in their specific experimental systems. This is especially crucial when using the antibody with different plant species or under non-standard conditions. The antibody has not been explicitly validated for other common applications such as immunohistochemistry (IHC), immunofluorescence (IF), or immunoprecipitation (IP), so preliminary testing would be required if these applications are intended.
Based on manufacturer recommendations, PCMP-H27 Antibody should be stored under the following conditions to maintain its activity and specificity:
| Storage Condition | Temperature | Duration |
|---|---|---|
| Long-term storage | -20°C to -80°C | Up to shelf life |
| Working solution | 2-8°C | Up to 1 month |
Critical handling considerations include:
Avoid repeated freeze-thaw cycles as they can degrade antibody performance
The antibody is provided in a liquid form with preservative (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4)
When preparing working dilutions, use fresh, sterile buffers
Maintain cold chain during handling to prevent protein denaturation
Proper storage and handling are crucial for maintaining antibody performance over time. Document any variations in storage conditions as they may affect experimental outcomes.
Determining the optimal working dilution for PCMP-H27 Antibody requires a systematic approach:
Initial titration experiment:
Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000, 1:10000)
Use consistent amounts of your Arabidopsis thaliana protein extract
Process all membranes identically (same blocking, washing, and detection conditions)
Evaluation criteria:
Signal-to-noise ratio (optimal dilution provides clear specific band with minimal background)
Signal intensity (sufficient for detection but not saturated)
Reproducibility across technical replicates
Optimization considerations:
Different extraction methods may affect epitope availability
Primary antibody incubation time (overnight at 4°C often yields better results than shorter incubations)
Blocking agent compatibility (BSA vs. non-fat dry milk)
As PCMP-H27 Antibody is polyclonal, you may observe multiple bands representing different isoforms or post-translational modifications of the target protein. Document the molecular weight of all observed bands and validate them using appropriate controls.
Remember that optimal dilutions may differ between applications (Western blot vs. ELISA) and sample types (whole cell lysate vs. purified protein).
Robust experimental design with PCMP-H27 Antibody should include the following controls:
Essential controls for validation:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive control | Confirms antibody reactivity | Use samples known to express PCMP-H27 (wild-type Arabidopsis thaliana tissue) |
| Negative control | Assesses non-specific binding | Use samples known not to express PCMP-H27 (knockout/knockdown lines or non-plant tissue) |
| Secondary antibody only | Evaluates background from secondary antibody | Omit primary antibody (PCMP-H27) but include all other reagents |
| Blocking peptide competition | Confirms specificity | Pre-incubate antibody with excess PCMP-H27 recombinant protein |
| Loading control | Normalizes for protein loading variations | Detect a housekeeping protein (e.g., actin, tubulin) in parallel |
Advanced controls for specific research questions:
For developmental studies: Include tissue samples from different developmental stages to track expression patterns
For stress response studies: Compare control vs. stressed plant samples to evaluate changes in expression
For subcellular localization: Include fractionation controls to verify compartment purity
The manufacturer provides pre-immune serum that can be used as a negative control alongside the PCMP-H27 Antibody to distinguish between specific and non-specific binding . This is particularly valuable when working with complex plant tissue samples.
Although PCMP-H27 Antibody is specifically raised against and validated for Arabidopsis thaliana proteins , researchers often need to evaluate its potential utility with related plant species. To systematically assess cross-reactivity:
Sequence homology analysis:
Compare the PCMP-H27 protein sequence (UniProt: O49619) from Arabidopsis thaliana with homologous proteins in your species of interest
Focus on conserved epitope regions (request this information from the manufacturer if possible)
Proteins with >70% sequence identity in key epitope regions have higher likelihood of cross-reactivity
Experimental validation protocol:
Perform Western blot analysis using protein extracts from:
a) Arabidopsis thaliana (positive control)
b) Your species of interest
c) An evolutionarily distant species (negative control)
Run samples on the same gel for direct comparison
Document all bands observed, including molecular weights
Confirmation experiments:
If bands of expected molecular weight are observed in your species of interest, confirm specificity through:
a) Mass spectrometry identification of the detected protein
b) Genetic approaches (analyzing knockout/knockdown lines if available)
c) Immunoprecipitation followed by mass spectrometry
Cross-reactivity studies should be comprehensively documented in your research, as this information is valuable to the broader scientific community working with plant antibodies.
When working with PCMP-H27 Antibody, researchers may encounter several technical challenges that can be systematically addressed:
| Potential Cause | Troubleshooting Approach |
|---|---|
| Insufficient protein | Increase loading amount; verify protein concentration measurement |
| Protein degradation | Add fresh protease inhibitors; keep samples cold; minimize freeze-thaw cycles |
| Inefficient transfer | Optimize transfer conditions for high molecular weight proteins; verify transfer with reversible stain |
| Suboptimal antibody concentration | Decrease dilution (use more concentrated antibody); extend incubation time |
| Epitope masking | Try different extraction buffers; consider denaturing vs. native conditions |
| Potential Cause | Troubleshooting Approach |
|---|---|
| Insufficient blocking | Increase blocking time; try alternative blocking agents (BSA vs. milk) |
| Cross-reactivity | Increase antibody dilution; pre-absorb with non-target tissue lysate |
| Secondary antibody issues | Increase secondary antibody dilution; try alternative secondary antibody |
| Insufficient washing | Extend washing steps; increase detergent concentration in wash buffer |
| Potential Cause | Troubleshooting Approach |
|---|---|
| Antibody stability issues | Aliquot antibody to avoid freeze-thaw cycles; verify storage conditions |
| Sample preparation variability | Standardize extraction protocol; include positive control in each experiment |
| Detection system variability | Use consistent exposure times; consider automated imaging systems |
As PCMP-H27 Antibody is a polyclonal preparation, some batch-to-batch variability may occur. Maintaining detailed records of antibody lot numbers used in experiments is essential for troubleshooting and reproducibility.
PCMP-H27 Antibody is purified using an antigen affinity method , which has significant implications for its performance in experimental applications:
Benefits of antigen affinity purification:
Enhanced specificity: The purification process selectively isolates antibodies that bind to the target antigen, reducing non-specific reactivity
Reduced background: Removal of antibodies that might cross-react with unrelated proteins
Batch consistency: More consistent performance compared to unpurified antisera
Higher effective concentration: The working dilution can often be higher (more dilute) than with unpurified antibodies
Experimental considerations:
Epitope bias: Antigen affinity purification may enrich for antibodies recognizing dominant epitopes while reducing those binding to minor epitopes
Conformation sensitivity: The purification process may select for antibodies recognizing specific conformational states, potentially affecting performance in different applications
Buffer compatibility: The storage buffer (0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4) is optimized for maintaining antibody stability but may impact certain applications:
High glycerol content may affect loading in gel applications
Proclin 300 preservative may interfere with some live cell applications
When designing critical experiments, researchers should consider how these properties might influence experimental outcomes and include appropriate controls to account for potential limitations.
When working with PCMP-H27 Antibody, researchers may observe multiple bands in Western blot applications. Proper interpretation requires consideration of several factors:
Possible biological explanations for multiple bands:
| Band Pattern | Potential Interpretation | Validation Approach |
|---|---|---|
| Multiple bands at different molecular weights | Isoforms from alternative splicing | RNA-seq or RT-PCR to identify transcript variants |
| Band slightly higher than expected MW | Post-translational modifications | Enzymatic treatment (e.g., phosphatase, glycosidase) |
| Bands at both expected MW and higher | Protein complexes resistant to denaturation | More stringent denaturation conditions |
| Bands at both expected MW and lower | Degradation products | Fresh sample preparation with additional protease inhibitors |
As PCMP-H27 is a plant protein expressed in Arabidopsis thaliana, researchers should consider species-specific factors that might influence band patterns, such as plant tissue type, developmental stage, and stress conditions.
Analytical approaches for band verification:
Molecular weight analysis: Calculate precise molecular weights using appropriate standards
Knockout/knockdown comparison: Compare wild-type to plants with reduced/eliminated target protein expression
Overexpression comparison: Compare to samples with known overexpression of the target
Peptide competition: Pre-incubate antibody with immunizing peptide to identify specific bands that disappear
Document all observed bands systematically, including their reproducibility across biological replicates, to distinguish between genuine target-related signals and experimental artifacts.
While PCMP-H27 Antibody has not been explicitly validated for immunoprecipitation (IP), researchers may explore this application with proper optimization. The following considerations are critical:
Pre-experimental assessment:
Binding capacity evaluation:
Test the antibody's ability to recognize native versus denatured protein
Perform a small-scale IP followed by Western blot to verify target enrichment
Consider the polyclonal nature of the antibody, which may recognize multiple epitopes (advantageous for IP)
Buffer optimization:
Test different lysis buffers to balance protein solubilization and epitope preservation
Consider plant-specific components that might interfere with antibody-antigen interaction
Evaluate the impact of detergent type and concentration on IP efficiency
IP protocol considerations:
| Protocol Stage | Key Considerations | Optimization Approach |
|---|---|---|
| Sample preparation | Plant cell walls and polyphenols can interfere | Include PVPP, optimize extraction buffer |
| Pre-clearing | Reduces non-specific binding | Use protein A/G beads before adding antibody |
| Antibody amount | Must be sufficient for target capture | Titrate antibody amount (typically 1-5 μg per sample) |
| Incubation conditions | Temperature affects binding kinetics | Compare 4°C overnight vs. room temperature shorter incubation |
| Washing stringency | Balance between purity and yield | Test different salt and detergent concentrations |
| Elution method | Impacts protein integrity and downstream applications | Compare SDS, low pH, and competitive elution |
Control samples for IP validation:
Input control: Sample before IP to verify target presence
No-antibody control: Beads only to assess non-specific binding
Isotype control: Irrelevant IgG to evaluate antibody-specific enrichment
Knockout/knockdown control: Sample lacking target protein to confirm specificity
The polyclonal nature of PCMP-H27 Antibody may provide advantages for IP by recognizing multiple epitopes, potentially improving capture efficiency compared to monoclonal antibodies that recognize single epitopes.
For quantitative analysis of PCMP-H27 protein expression, researchers can employ several approaches, each with distinct advantages and limitations:
Quantitative Western blotting:
Sample preparation standardization:
Consistent extraction method across all samples
Accurate protein quantification (BCA or Bradford assay)
Equal protein loading verified by total protein stain (Ponceau S)
Technical considerations:
Linear dynamic range determination through standard curve
Use of housekeeping proteins as loading controls (e.g., actin, tubulin)
Digital image acquisition within linear range of detection
Data analysis:
Densitometric analysis of bands using appropriate software
Normalization to loading controls
Statistical analysis across biological replicates
Quantitative ELISA development:
The manufacturer has validated PCMP-H27 Antibody for ELISA applications , making this a viable approach for quantification:
| ELISA Component | Optimization Consideration | Recommended Approach |
|---|---|---|
| Coating antibody | Concentration and buffer | Titrate between 1-10 μg/mL in carbonate buffer |
| Blocking agent | Minimize background without affecting antibody binding | Compare BSA vs. non-fat dry milk effectiveness |
| Sample preparation | Matrix effects | Develop dilution series to identify linear range |
| Detection system | Sensitivity requirements | HRP vs. AP enzyme systems based on sensitivity needs |
| Standard curve | Quantification reference | Recombinant PCMP-H27 protein in serial dilutions |
Advanced quantitative applications:
Multiplexed analysis: Combine PCMP-H27 detection with other proteins of interest when studying related pathways
Spatial analysis: Combine with imaging techniques to assess protein distribution in different cell types or subcellular compartments
Temporal analysis: Track expression changes across developmental stages or in response to environmental stimuli
When reporting quantitative results, include detailed methodology and acknowledge the limitations of the quantification approach used, particularly noting any assumptions made about the relationship between signal intensity and protein quantity.
Plant stress response research presents unique challenges and opportunities when using PCMP-H27 Antibody:
Experimental design considerations:
Stress treatment standardization:
Define precise stress conditions (duration, intensity)
Include time-course sampling to capture dynamic changes
Use consistent plant developmental stages across experiments
Sample processing challenges:
Stress conditions may alter protein extraction efficiency
Some stressors induce proteolytic activity requiring modified extraction protocols
Stress may induce post-translational modifications affecting antibody recognition
Controls specific to stress studies:
Paired stressed/unstressed samples from same plant population
Gradient of stress intensities to establish dose-response
Recovery time points to assess reversibility of changes
Analytical approaches:
| Research Question | Methodological Approach | Key Controls |
|---|---|---|
| Changes in protein abundance | Quantitative Western blot with normalization | Multiple reference proteins unaffected by stress |
| Altered subcellular localization | Fractionation followed by immunoblotting | Fraction purity markers |
| Post-translational modifications | 2D gel electrophoresis or phospho-specific detection | Enzymatic treatment (phosphatase, etc.) |
| Protein-protein interactions | Co-immunoprecipitation or proximity ligation | Interaction disruption controls |
When reporting findings, explicitly describe all stress conditions and sample processing methods in detail, as these factors significantly impact experimental outcomes and reproducibility in plant stress research.
When extending PCMP-H27 Antibody research beyond the standard Arabidopsis thaliana Columbia (Col-0) ecotype, researchers should implement a systematic approach:
Sequence variation considerations:
In silico analysis:
Compare PCMP-H27 protein sequences across ecotypes/species
Identify conserved regions most likely to contain antibody epitopes
Evaluate potential impact of amino acid substitutions on antibody recognition
Preliminary validation experiments:
Western blot comparison across ecotypes/species using identical conditions
Document variations in band patterns, intensity, and molecular weight
Consider gradient gels to better resolve small molecular weight differences
Experimental design for comparative studies:
| Approach | Advantages | Limitations | Implementation |
|---|---|---|---|
| Side-by-side comparison | Direct visualization of differences | Limited to fewer samples | Run samples on same gel/membrane |
| Reference sample inclusion | Facilitates cross-experiment comparison | Requires consistent reference | Include Col-0 standard on each blot |
| Normalization strategy | Accounts for technical variation | Assumes stable reference | Use conserved proteins as loading controls |
Data interpretation considerations:
Distinguish technical from biological variation:
Conduct replicate experiments to establish reproducibility
Consider extraction efficiency differences between species/ecotypes
Evaluate antibody affinity variations due to sequence differences
Complementary approaches:
mRNA expression analysis to correlate with protein levels
Recombinant protein standards from each species/ecotype
Genetic complementation studies to confirm functional equivalence
When publishing comparative studies, explicitly acknowledge the limitations of antibody-based approaches across diverse genetic backgrounds and validate key findings using complementary methods whenever possible.
Investigating protein-protein interactions involving the PCMP-H27 protein can provide valuable insights into its functional roles. Several advanced techniques can be employed in conjunction with PCMP-H27 Antibody:
Co-immunoprecipitation (Co-IP) approaches:
Forward Co-IP:
Immunoprecipitate PCMP-H27 using the antibody
Identify co-precipitating proteins by mass spectrometry or immunoblotting
Critical controls: IgG control, antibody-only control, knockout/knockdown control
Reverse Co-IP:
Immunoprecipitate suspected interacting partners
Detect PCMP-H27 in the precipitated complex using the antibody
Validates interactions identified in forward Co-IP
Proximity-based methods:
| Technique | Principle | Application with PCMP-H27 Antibody |
|---|---|---|
| Proximity Ligation Assay (PLA) | Detects proteins in close proximity (<40 nm) | Combine PCMP-H27 Antibody with antibody against potential interactor |
| FRET/FLIM | Energy transfer between fluorophores | Label PCMP-H27 Antibody and interactor antibody with compatible fluorophores |
| BiFC complementation | Split fluorescent protein reassembly | Not directly using antibody but validates interactions |
Emerging technologies:
Antibody-based proximity labeling:
Conjugate PCMP-H27 Antibody to proximity labeling enzyme (BioID, APEX)
Label proteins in close proximity to PCMP-H27 in living cells
Identify labeled proteins by mass spectrometry
Antibody-mediated chromatin immunoprecipitation (ChIP):
If PCMP-H27 has DNA-binding properties, use the antibody for ChIP
Identify genomic regions associated with PCMP-H27
Combine with RNA-IP to connect with RNA processing functions
For all interaction studies, rigorous validation is essential due to the complex nature of plant cellular environments. False positives can arise from indirect associations within larger complexes, so orthogonal validation methods should be employed to confirm direct interactions.
The application of PCMP-H27 Antibody in developmental biology presents opportunities to understand the temporal and spatial regulation of this protein throughout plant life cycles:
Developmental expression profiling:
Tissue-specific analysis:
Systematic sampling of different plant tissues (roots, shoots, leaves, flowers, seeds)
Protein extraction optimized for each tissue type
Quantitative Western blotting to compare expression levels
Correlation with tissue-specific functions and phenotypes
Developmental time-course studies:
Sampling at defined developmental stages from germination to senescence
Standardized growth conditions to minimize environmental variables
Documentation of expression patterns in relation to developmental transitions
Integration with transcriptomic data to identify post-transcriptional regulation
Advanced visualization approaches:
| Technique | Application | Considerations with PCMP-H27 Antibody |
|---|---|---|
| Immunohistochemistry | Tissue-level localization | Fixation optimization to preserve epitopes |
| Whole-mount immunofluorescence | 3D protein distribution | Tissue clearing to improve antibody penetration |
| Super-resolution microscopy | Subcellular localization | Secondary antibody selection compatible with technique |
Functional developmental studies:
Connection to phenotypic analysis:
Correlate PCMP-H27 expression with developmental phenotypes
Compare wild-type to mutant developmental trajectories
Rescue experiments with controlled expression
Integration with plant hormone signaling:
Analyze PCMP-H27 expression in response to hormone treatments
Investigate potential role in hormone-regulated developmental processes
Combine with hormone biosynthesis/signaling mutants
While the antibody has not been validated specifically for all these applications, systematic optimization can potentially expand its utility in developmental biology research. The polyclonal nature of the antibody may be advantageous for detecting various protein states across developmental contexts.
Integrating PCMP-H27 Antibody with mass spectrometry approaches can provide powerful insights into protein abundance, modifications, and interactions:
Immunoprecipitation-mass spectrometry (IP-MS) workflow:
Sample preparation optimization:
Extraction buffer compatibility with both IP and MS
Minimization of detergents that interfere with MS
Incorporation of plant-specific considerations (secondary metabolites, cell wall components)
IP protocol refinement:
Antibody coupling to beads to prevent antibody contamination in MS samples
Optimized washing to reduce non-specific binding
Elution methods compatible with downstream MS processing
MS sample processing:
In-solution vs. in-gel digestion comparison
Appropriate protease selection (trypsin, Lys-C, or combination)
Peptide cleanup and fractionation strategies
Quantitative approaches:
| Method | Application | Implementation with PCMP-H27 Antibody |
|---|---|---|
| Label-free quantification | Relative abundance across samples | Direct comparison after immunoprecipitation |
| SILAC or metabolic labeling | Precise ratio measurement | Challenging in plants; alternative labeling needed |
| TMT/iTRAQ labeling | Multiplexed comparison | Post-IP labeling of precipitated proteins |
| Selected reaction monitoring (SRM) | Targeted quantification | Development of specific PCMP-H27 peptide transitions |
Data analysis considerations:
PCMP-H27 sequence coverage assessment:
Identification of consistently detected peptides
Evaluation of sequence coverage across protein domains
Analysis of missed cleavages and modifications
Interactome analysis:
Statistical filtering to identify significant interactors
Comparison to control IPs for specificity determination
Network analysis of identified protein interactions
Modification mapping:
Identification of post-translational modifications
Site localization probability assessment
Quantification of modification stoichiometry
The combination of immunoprecipitation with mass spectrometry leverages the specificity of the antibody with the analytical power of MS, enabling multidimensional analysis of PCMP-H27 biology beyond traditional antibody applications.
To ensure robust and reproducible research outcomes when using PCMP-H27 Antibody, implement these comprehensive validation practices:
Documentation and reporting standards:
Detailed antibody information:
Complete catalog information (CSB-PA528652XA01DOA)
Lot number and purchase date
Storage and handling conditions
Working dilution and optimization process
Experimental validation evidence:
Images of full blots including molecular weight markers
All controls run in parallel
Replicate data demonstrating reproducibility
Alternative methods supporting key findings
Cross-validation approaches:
| Validation Method | Implementation | Advantage |
|---|---|---|
| Genetic validation | Compare wild-type vs. knockout/knockdown | Definitively establishes signal specificity |
| Multiple antibody validation | Use antibodies targeting different epitopes | Confirms identity of detected protein |
| Recombinant protein controls | Include purified protein standards | Verifies expected molecular weight and reactivity |
| Orthogonal techniques | Complement antibody data with MS or RT-PCR | Provides technique-independent verification |
Transparency in limitations:
Acknowledge antibody limitations:
Potential cross-reactivity profiles
Application-specific performance variations
Batch-to-batch consistency considerations
Address technical challenges:
Document troubleshooting approaches
Report optimization parameters
Share negative results when relevant
By implementing these validation practices, researchers not only enhance the reliability of their own findings but also contribute to the broader scientific community by establishing standards for antibody usage in plant research.
The integration of computational approaches with experimental PCMP-H27 Antibody data creates powerful opportunities for deeper biological insights:
Sequence and structure analysis:
Epitope prediction:
Computational analysis of PCMP-H27 sequence for likely antibody epitopes
Correlation with experimental data on antibody recognition
Prediction of potential cross-reactivity with related proteins
Structural modeling:
Prediction of PCMP-H27 protein structure
Mapping of antibody binding regions on structural models
Evaluation of conformational epitopes
Integrative data analysis:
| Computational Approach | Application | Integration with Antibody Data |
|---|---|---|
| Transcriptomics correlation | mRNA-protein relationship analysis | Compare protein levels (antibody) with transcript levels |
| Protein-protein interaction networks | Functional context prediction | Place immunoprecipitation results in interaction networks |
| Phylogenetic analysis | Evolutionary conservation | Predict antibody utility across species based on sequence conservation |
Advanced modeling applications:
Pathway modeling:
Incorporate quantitative antibody data into systems biology models
Simulate effects of PCMP-H27 perturbation on biological pathways
Generate testable hypotheses for further experiments
Multi-omics integration:
Combine antibody-based protein data with transcriptomics, metabolomics
Develop integrated models of biological processes
Identify emergent properties not apparent in single-omics approaches